This media requires:
- Javascript to be turned on
- and one of the following:
- An HTML5-compatible browser or
- Adobe Flash Player version 8 and higher
November 7, 2012
Recorded November 6, 2012
An international panel of the world's top cardiologists gathered together in Los Angeles to tackle the issues raised by the major trials presented at the American Heart Association (AHA) 2012 Scientific Sessions.
Join Dr Valentin Fuster for an in-depth discussion with Drs C Noel Bairey Merz, Robert Harrington, Gilles Montalescot, Rita Redberg, Lars Wallentin, and Clyde Yancy on what FREEDOM means for interventional cardiologists, why chelation therapy is still being studied, the future of the polypill, and what to do about multivitamins.
Recorded November 6, 2012
An international panel of the world's top cardiologists gathered together in Los Angeles to tackle the issues raised by the major trials presented at the American Heart Association (AHA) 2012 Scientific Sessions.
Join Dr Valentin Fuster for an in-depth discussion with Drs C Noel Bairey Merz, Robert Harrington, Gilles Montalescot, Rita Redberg, Lars Wallentin, and Clyde Yancy on what FREEDOM means for interventional cardiologists, why chelation therapy is still being studied, the future of the polypill, and what to do about multivitamins.
Chair
Valentin Fuster MD PhD
Director, Mount Sinai Heart
Director, Zena and Michael Wiener Cardiovascular Institute and the Marie-Josée and Henry R Kravis Center of Cardiovascular Health
Richard Gorlin MD Heart Research Foundation Professor of Cardiology at Mount Sinai Medical Center
New York, NY
Dr Fuster has no relevant financial relationships to disclose.
Director, Mount Sinai Heart
Director, Zena and Michael Wiener Cardiovascular Institute and the Marie-Josée and Henry R Kravis Center of Cardiovascular Health
Richard Gorlin MD Heart Research Foundation Professor of Cardiology at Mount Sinai Medical Center
New York, NY
Dr Fuster has no relevant financial relationships to disclose.
Panelists
C Noel Bairey Merz MD
Director, Women's Heart Center
Director, Preventive and Rehabilitative Cardiac Center
Women's Guild Endowed Chair in Women's Health
Heart Institute
Professor of Medicine
Cedars-Sinai Medical Center
Los Angeles, CA
Dr Bairey Merz has received honoraria (paid to Cedars-Sinai Medical Center) for consulting for Amarin, Allegeny Hospital, Brigham and Women's Hospital, CV Institute of San Diego, Christiana Health System, El Camino Hospital, Expert Exchange, Gilead, Mayo Foundation, Montefiore Medical Center, Medscape, NIH, NHLBI, Pozen, SCS Healthcare, Society for Women's Health Research, Slocum-Dickson, and the Women's Health Congress. Dr Bairey Merz has received honoraria (paid to her) for consulting for Abbott Vascular, Los Robles Medical Center, and the University of Pennsylvania.
Gilles Montalescot MD PhD
Professor of Cardiology, Institut de Cardiologie, Hôpital la Pitié-Salpêtrière
Paris, France
Dr Montalescot has received grants for clinical research from Medica, AstraZeneca, Biotronik, Boston Scientific, Bristol-Myers Squibb, Daiichi Sankyo, Eli Lilly, Medtronic, Nanosphere, Pfizer, Roche, Sanofi, Stago, Stentys, and Thermo Fisher. Dr Montalescot has served as a consultant for or received lecture fees from Abbott, AstraZeneca, Atrium Medical, Bayer, Biotronik, Boehringer Ingelheim, Daiichi Sankyo, Eisai, Eli Lilly, GlaxoSmithKline, Indegene Lifesystems, Menarini Group, Merck Sharp and Dohme, Nanosphere, Novartis, Pfizer, Portola, Sanofi, the Medicines Company, Asante, Lead-up, and Springer.
Lars Wallentin MD PhD
Professor of Cardiology
Director, Uppsala Clinical Research Center, University Hospital
Uppsala, Sweden
Dr Wallentin has served as an advisor or consultant for Athera Biotechnologies, CSL Behring, Evolva, Portola, and Regado Biosciences. He has received grants for clinical research from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, and Schering-Plough.
Robert Harrington MD
Arthur L Bloomfield Professor of Medicine and Chair, Department of Medicine
Stanford University
Stanford, CA
Dr Harrington has served as an advisor or consultant for APT Therapeutics, AstraZeneca, Baxter, Boehringer Ingelheim, Bristol-Myers Squibb, Cortex, CSL Behring, Daiichi Sankyo, Eisai, Genentech, Gilead, Johnson & Johnson, Merck, Mitsubishi Tanabe, Momenta, Nidus Center for Scientific Enterprise, Orexigen, Pfizer, Regado, Sanofi, and the Medicines Company. He has received grants for clinical research from AstraZeneca, Baxter, Bristol-Myers Squibb, CSL Behring, GlaxoSmithKline, Merck, Portola, Sanofi, and the Medicines Company.
Rita Redberg MD
Professor of Medicine
Director, Women's Cardiovascular Services
Division of Cardiology
University of California San Francisco Medical Center
San Francisco, CA
Dr Redberg has disclosed no relevant financial relationships.
Clyde Yancy MD MSc
Magerstadt Professor of Medicine, Chief of Cardiology, Northwestern University, Feinberg School of Medicine,
Chicago, Illinois
Dr Yancy has disclosed no relevant financial relationships.
Director, Women's Heart Center
Director, Preventive and Rehabilitative Cardiac Center
Women's Guild Endowed Chair in Women's Health
Heart Institute
Professor of Medicine
Cedars-Sinai Medical Center
Los Angeles, CA
Dr Bairey Merz has received honoraria (paid to Cedars-Sinai Medical Center) for consulting for Amarin, Allegeny Hospital, Brigham and Women's Hospital, CV Institute of San Diego, Christiana Health System, El Camino Hospital, Expert Exchange, Gilead, Mayo Foundation, Montefiore Medical Center, Medscape, NIH, NHLBI, Pozen, SCS Healthcare, Society for Women's Health Research, Slocum-Dickson, and the Women's Health Congress. Dr Bairey Merz has received honoraria (paid to her) for consulting for Abbott Vascular, Los Robles Medical Center, and the University of Pennsylvania.
Professor of Cardiology, Institut de Cardiologie, Hôpital la Pitié-Salpêtrière
Paris, France
Dr Montalescot has received grants for clinical research from Medica, AstraZeneca, Biotronik, Boston Scientific, Bristol-Myers Squibb, Daiichi Sankyo, Eli Lilly, Medtronic, Nanosphere, Pfizer, Roche, Sanofi, Stago, Stentys, and Thermo Fisher. Dr Montalescot has served as a consultant for or received lecture fees from Abbott, AstraZeneca, Atrium Medical, Bayer, Biotronik, Boehringer Ingelheim, Daiichi Sankyo, Eisai, Eli Lilly, GlaxoSmithKline, Indegene Lifesystems, Menarini Group, Merck Sharp and Dohme, Nanosphere, Novartis, Pfizer, Portola, Sanofi, the Medicines Company, Asante, Lead-up, and Springer.
Professor of Cardiology
Director, Uppsala Clinical Research Center, University Hospital
Uppsala, Sweden
Dr Wallentin has served as an advisor or consultant for Athera Biotechnologies, CSL Behring, Evolva, Portola, and Regado Biosciences. He has received grants for clinical research from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, and Schering-Plough.
Arthur L Bloomfield Professor of Medicine and Chair, Department of Medicine
Stanford University
Stanford, CA
Dr Harrington has served as an advisor or consultant for APT Therapeutics, AstraZeneca, Baxter, Boehringer Ingelheim, Bristol-Myers Squibb, Cortex, CSL Behring, Daiichi Sankyo, Eisai, Genentech, Gilead, Johnson & Johnson, Merck, Mitsubishi Tanabe, Momenta, Nidus Center for Scientific Enterprise, Orexigen, Pfizer, Regado, Sanofi, and the Medicines Company. He has received grants for clinical research from AstraZeneca, Baxter, Bristol-Myers Squibb, CSL Behring, GlaxoSmithKline, Merck, Portola, Sanofi, and the Medicines Company.
Professor of Medicine
Director, Women's Cardiovascular Services
Division of Cardiology
University of California San Francisco Medical Center
San Francisco, CA
Dr Redberg has disclosed no relevant financial relationships.
Magerstadt Professor of Medicine, Chief of Cardiology, Northwestern University, Feinberg School of Medicine,
Chicago, Illinois
Dr Yancy has disclosed no relevant financial relationships.
Related links:
